Industrial Bio-Processing

Advanced Enzyme Technologies reported Q4 FY26 consolidated revenue of ₹2,034 million, an 18% sequential growth. Q4 PAT increased 69% YoY to ₹453 million, with EBITDA growing 28% QoQ to ₹632 million. H